STOCKHOLDER SUPPORT AGREEMENTStockholder Support Agreement • July 3rd, 2008 • Stiefel Laboratories, Inc. • Pharmaceutical preparations • Delaware
STOCKHOLDER SUPPORT AGREEMENT, dated as of June 23, 2008 (this “Agreement”), by and among Stiefel Laboratories, Inc., a Delaware corporation (“Parent”) and Geert Cauwenbergh, Ph.D. (the “Stockholder”). Capitalized terms used but not defined herein shall have the meanings given to such terms in the Merger Agreement.
STOCKHOLDER SUPPORT AGREEMENTStockholder Support Agreement • July 3rd, 2008 • Stiefel Laboratories, Inc. • Pharmaceutical preparations • Delaware
STOCKHOLDER SUPPORT AGREEMENT, dated as of June 30, 2008 (this “Agreement”), by and among Stiefel Laboratories, Inc., a Delaware corporation (“Parent”), and JPMP Capital Corp. (the “Stockholder”). This Agreement shall be effective as of June 23, 2008. Capitalized terms used but not defined herein shall have the meanings given to such terms in the Merger Agreement.
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)Joint Filing Agreement • July 3rd, 2008 • Stiefel Laboratories, Inc. • Pharmaceutical preparations
The undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D may be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein or therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.
